MYCN as a target for cancer immunotherapy

Amplification of N- <i>myc</i> in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage

Garrett M. Brodeur, Robert C. Seeger, Manfred Schwab et al. · Science · 1984 · 2.3K citations

Medicine, Molecular Biology, Oncology +11

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang et al. · Journal of Clinical Oncology · 2005 · 1.6K citations · Full text

Medicine, Immunology, Oncology +17

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

Willem W. Overwijk, Marc R. Theoret, Steven E. Finkelstein et al. · The Journal of Experimental Medicine · 2003 · 918 citations · Full text

Life Sciences, Immunology, Oncology +17

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15

Renier J. Brentjens, Jean‐Baptiste Latouche, Elmer Santos et al. · Nature Medicine · 2003 · 662 citations

Life Sciences, Immunology, Oncology +14

Differential expression of myc family genes during murine development

Kathryn A. Zimmerman, George D. Yancopoulos, Robert G. Collum et al. · Nature · 1986 · 548 citations

Life Sciences, Genetics, Molecular Biology +15